146 related articles for article (PubMed ID: 24333336)
21. (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E
Kuroyanagi G; Tokuda H; Yamamoto N; Kainuma S; Fujita K; Ohguchi R; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Harada A; Kozawa O; Otsuka T
Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():27-33. PubMed ID: 28163121
[TBL] [Abstract][Full Text] [Related]
22. Oncostatin M stimulates prostaglandin D
Kuroyanagi G; Hioki T; Tachi J; Matsushima-Nishiwaki R; Iida H; Kozawa O; Tokuda H
Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102575. PubMed ID: 37094446
[TBL] [Abstract][Full Text] [Related]
23. PGD2 stimulates osteoprotegerin synthesis via AMP-activated protein kinase in osteoblasts: Regulation of ERK and SAPK/JNK.
Kainuma S; Tokuda H; Kuroyanagi G; Yamamoto N; Ohguchi R; Fujita K; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
Prostaglandins Leukot Essent Fatty Acids; 2015 Oct; 101():23-9. PubMed ID: 26365271
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol inhibits BMP-4-stimulated VEGF synthesis in osteoblasts: suppression of S6 kinase.
Kondo A; Otsuka T; Kuroyanagi G; Yamamoto N; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
Int J Mol Med; 2014 Apr; 33(4):1013-8. PubMed ID: 24435444
[TBL] [Abstract][Full Text] [Related]
25. Minodronate suppresses prostaglandin F2alpha-induced vascular endothelial growth factor synthesis in osteoblasts.
Hanai Y; Tokuda H; Takai S; Harada A; Ohta T; Kozawa O
Horm Metab Res; 2006 Mar; 38(3):152-8. PubMed ID: 16673205
[TBL] [Abstract][Full Text] [Related]
26. Resveratrol suppresses TGF-β-induced VEGF synthesis in osteoblasts: Inhibition of the p44/p42 MAPKs and SAPK/JNK pathways.
Kuroyanagi G; Otsuka T; Yamamoto N; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Exp Ther Med; 2015 Jun; 9(6):2303-2310. PubMed ID: 26136978
[TBL] [Abstract][Full Text] [Related]
27. Involvement of p42/p44 mitogen-activated protein kinase in prostaglandin f(2alpha)-stimulated induction of heat shock protein 27 in osteoblasts.
Kozawa O; Tokuda H; Miwa M; Ito H; Matsuno H; Niwa M; Kato K; Uematsu T
J Cell Biochem; 1999 Dec; 75(4):610-9. PubMed ID: 10572244
[TBL] [Abstract][Full Text] [Related]
28. Negative regulation by p70 S6 kinase of FGF-2-stimulated VEGF release through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Takai S; Tokuda H; Hanai Y; Harada A; Yasuda E; Matsushima-Nishiwaki R; Kato H; Ogura S; Ohta T; Kozawa O
J Bone Miner Res; 2007 Mar; 22(3):337-46. PubMed ID: 17181399
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol suppresses thyroid hormone‑induced osteocalcin synthesis in osteoblasts.
Fujita K; Tokuda H; Kainuma S; Kuroyanagi G; Yamamoto N; Matsushima-Nishiwaki R; Harada A; Kozawa O; Otsuka T
Mol Med Rep; 2017 Sep; 16(3):2881-2886. PubMed ID: 28677796
[TBL] [Abstract][Full Text] [Related]
30. Platelet-derived growth factor-BB amplifies PGF2alpha-stimulated VEGF synthesis in osteoblasts: function of phosphatidylinositol 3-kinase.
Tokuda H; Takai S; Hanai Y; Harada A; Matsushima-Nishiwaki R; Akamatsu S; Ohta T; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):187-93. PubMed ID: 17980568
[TBL] [Abstract][Full Text] [Related]
31. Wnt3a upregulates prostaglandin F2α-stimulated vascular endothelial growth factor synthesis in osteoblasts.
Kondo A; Tokuda H; Mizutani J; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
Mol Med Rep; 2012 Aug; 6(2):421-5. PubMed ID: 22614766
[TBL] [Abstract][Full Text] [Related]
32. Attenuation of prostaglandin E1‑induced osteoprotegerin synthesis in osteoblasts by normoxic HIF inducers.
Kuroyanagi G; Tokuda H; Yamamoto N; Kainuma S; Fujita K; Ohguchi R; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
Mol Med Rep; 2017 Apr; 15(4):1847-1852. PubMed ID: 28259984
[TBL] [Abstract][Full Text] [Related]
33. Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts.
Kozawa O; Hatakeyama D; Uematsu T
J Cell Biochem; 2002; 84(3):583-9. PubMed ID: 11813263
[TBL] [Abstract][Full Text] [Related]
34. Zinc suppresses IL-6 synthesis by prostaglandin F2alpha in osteoblasts: inhibition of phospholipase C and phospholipase D.
Hatakeyama D; Kozawa O; Otsuka T; Shibata T; Uematsu T
J Cell Biochem; 2002; 85(3):621-8. PubMed ID: 11968002
[TBL] [Abstract][Full Text] [Related]
35. Involvement of SAPK/JNK in prostaglandin E(1)-induced VEGF synthesis in osteoblast-like cells.
Kanno Y; Tokuda H; Nakajima K; Ishisaki A; Shibata T; Numata O; Kozawa O
Mol Cell Endocrinol; 2004 May; 220(1-2):89-95. PubMed ID: 15196703
[TBL] [Abstract][Full Text] [Related]
36. Amplification by tramadol of PGD
Hioki T; Tokuda H; Tanabe K; Kim W; Tachi J; Yamaguchi S; Matsushima-Nishiwaki R; Kozawa O; Iida H
Prostaglandins Leukot Essent Fatty Acids; 2021 Sep; 172():102323. PubMed ID: 34392133
[TBL] [Abstract][Full Text] [Related]
37. Zinc upregulates the expression of osteoprotegerin in mouse osteoblasts MC3T3-E1 through PKC/MAPK pathways.
Liang D; Yang M; Guo B; Cao J; Yang L; Guo X
Biol Trace Elem Res; 2012 Jun; 146(3):340-8. PubMed ID: 22081405
[TBL] [Abstract][Full Text] [Related]
38. SAPK/JNK plays a role in transforming growth factor-beta-induced VEGF synthesis in osteoblasts.
Kanno Y; Ishisaki A; Yoshida M; Tokuda H; Numata O; Kozawa O
Horm Metab Res; 2005 Mar; 37(3):140-5. PubMed ID: 15824967
[TBL] [Abstract][Full Text] [Related]
39. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation.
Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Hosoi T; Harada A; Ohta T; Kozawa O
FEBS Lett; 2007 Apr; 581(7):1311-6. PubMed ID: 17350626
[TBL] [Abstract][Full Text] [Related]
40. Gallein increases the fibroblast growth factor 2-elicited osteoprotegerin synthesis in osteoblasts.
Kuroyanagi G; Hioki T; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Biochim Biophys Acta Gen Subj; 2024 Aug; 1868(8):130635. PubMed ID: 38788984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
